Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016492767> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2016492767 endingPage "1744" @default.
- W2016492767 startingPage "1742" @default.
- W2016492767 abstract "Recent studies showed that rituximab, a chimeric anti-CD20 monoclonal antibody, reduces antibody levels and ameliorates neuropathy in two thirds of patients with neuropathy and anti-myelin-associated glycoprotein (MAG) monoclonal IgM.1–3 Few data are available on the long-term effects of this therapy.4 We report on the long-term follow-up of rituximab responders with anti-MAG polyneuropathy.### Methods.Ten patients with anti-MAG polyneuropathy responding to rituximab, 375 mg/sq for four consecutive weekly infusions, were prospectively studied for 36 months. The effects of the initial treatment in 13 patients and the type of assessment were previously described.3 The baseline clinical and laboratory data of the 10 responding patients are reported in the table. All but one patient (no. 1) had an IgM monoclonal gammopathy of undetermined significance and a symptom duration of up to 2 years. Three patients had not been previously treated for the neuropathy, whereas seven were unresponsive to immune or cytostatic therapies. We considered as responders patients who improved at month 12 by at least one point in two clinical scales including MRC sumscore (appendix e-1 on the Neurology ® Web site at www.neurology.org), INCAT Disability Scale (appendix e-2), and INCAT sensory sumscore (ISS) …" @default.
- W2016492767 created "2016-06-24" @default.
- W2016492767 creator A5009280913 @default.
- W2016492767 creator A5011243917 @default.
- W2016492767 creator A5020120126 @default.
- W2016492767 creator A5021419385 @default.
- W2016492767 creator A5032510994 @default.
- W2016492767 creator A5038006814 @default.
- W2016492767 creator A5058570193 @default.
- W2016492767 creator A5062099532 @default.
- W2016492767 creator A5063579345 @default.
- W2016492767 creator A5066814162 @default.
- W2016492767 creator A5084080564 @default.
- W2016492767 date "2008-11-17" @default.
- W2016492767 modified "2023-10-16" @default.
- W2016492767 title "LONG-TERM EFFECT OF RITUXIMAB IN ANTI-MAG POLYNEUROPATHY" @default.
- W2016492767 doi "https://doi.org/10.1212/01.wnl.0000335268.70325.33" @default.
- W2016492767 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19015493" @default.
- W2016492767 hasPublicationYear "2008" @default.
- W2016492767 type Work @default.
- W2016492767 sameAs 2016492767 @default.
- W2016492767 citedByCount "71" @default.
- W2016492767 countsByYear W20164927672012 @default.
- W2016492767 countsByYear W20164927672013 @default.
- W2016492767 countsByYear W20164927672014 @default.
- W2016492767 countsByYear W20164927672015 @default.
- W2016492767 countsByYear W20164927672016 @default.
- W2016492767 countsByYear W20164927672017 @default.
- W2016492767 countsByYear W20164927672018 @default.
- W2016492767 countsByYear W20164927672019 @default.
- W2016492767 countsByYear W20164927672020 @default.
- W2016492767 countsByYear W20164927672021 @default.
- W2016492767 countsByYear W20164927672022 @default.
- W2016492767 crossrefType "journal-article" @default.
- W2016492767 hasAuthorship W2016492767A5009280913 @default.
- W2016492767 hasAuthorship W2016492767A5011243917 @default.
- W2016492767 hasAuthorship W2016492767A5020120126 @default.
- W2016492767 hasAuthorship W2016492767A5021419385 @default.
- W2016492767 hasAuthorship W2016492767A5032510994 @default.
- W2016492767 hasAuthorship W2016492767A5038006814 @default.
- W2016492767 hasAuthorship W2016492767A5058570193 @default.
- W2016492767 hasAuthorship W2016492767A5062099532 @default.
- W2016492767 hasAuthorship W2016492767A5063579345 @default.
- W2016492767 hasAuthorship W2016492767A5066814162 @default.
- W2016492767 hasAuthorship W2016492767A5084080564 @default.
- W2016492767 hasConcept C121332964 @default.
- W2016492767 hasConcept C126322002 @default.
- W2016492767 hasConcept C2775892965 @default.
- W2016492767 hasConcept C2779338263 @default.
- W2016492767 hasConcept C2780653079 @default.
- W2016492767 hasConcept C61797465 @default.
- W2016492767 hasConcept C62520636 @default.
- W2016492767 hasConcept C71924100 @default.
- W2016492767 hasConceptScore W2016492767C121332964 @default.
- W2016492767 hasConceptScore W2016492767C126322002 @default.
- W2016492767 hasConceptScore W2016492767C2775892965 @default.
- W2016492767 hasConceptScore W2016492767C2779338263 @default.
- W2016492767 hasConceptScore W2016492767C2780653079 @default.
- W2016492767 hasConceptScore W2016492767C61797465 @default.
- W2016492767 hasConceptScore W2016492767C62520636 @default.
- W2016492767 hasConceptScore W2016492767C71924100 @default.
- W2016492767 hasIssue "21" @default.
- W2016492767 hasLocation W20164927671 @default.
- W2016492767 hasLocation W20164927672 @default.
- W2016492767 hasOpenAccess W2016492767 @default.
- W2016492767 hasPrimaryLocation W20164927671 @default.
- W2016492767 hasRelatedWork W1506200166 @default.
- W2016492767 hasRelatedWork W1995515455 @default.
- W2016492767 hasRelatedWork W2048182022 @default.
- W2016492767 hasRelatedWork W2080531066 @default.
- W2016492767 hasRelatedWork W2604872355 @default.
- W2016492767 hasRelatedWork W2748952813 @default.
- W2016492767 hasRelatedWork W2899084033 @default.
- W2016492767 hasRelatedWork W3031052312 @default.
- W2016492767 hasRelatedWork W3032375762 @default.
- W2016492767 hasRelatedWork W3108674512 @default.
- W2016492767 hasVolume "71" @default.
- W2016492767 isParatext "false" @default.
- W2016492767 isRetracted "false" @default.
- W2016492767 magId "2016492767" @default.
- W2016492767 workType "article" @default.